Associated Papers
Genetic Architecture Associated With Familial Short Stature.
Lin YJ et al.
The Journal of Clinical Endocrinology and Metabolism, 2020
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.
Johansson H et al.
The Pharmacogenomics Journal, 2020
UGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus.
Lian X et al.
Bioscience Reports, 2019
Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver.
Bhatt DK et al.
Clinical Pharmacology and Therapeutics, 2019
Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.
Papageorgiou I et al.
Biochemical Pharmacology, 2017
Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
Habibi M et al.
Gene, 2017
Human hepatic UGT2B15 developmental expression.
Divakaran K et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology, 2014
Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.
Grant DJ et al.
Genetic Testing and Molecular Biomarkers, 2013
Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3'UTR.
Sun C et al.
Gene, 2011
Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
Deshmukh N et al.
Substance Abuse Treatment, Prevention, and Policy, 2010
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2010
Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.
Balliet RM et al.
Cancer Research, 2009
Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.
Schulze JJ et al.
Pharmacogenetics and Genomics, 2008
The interaction of genetic polymorphisms with lifestyle factors: implications for the dietary prevention of prostate cancer.
Nelson EC et al.
Nutrition and Cancer, 2008
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Park J et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2006
Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
Lévesque E et al.
Pharmacogenetics, 1997